Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A synthetic small molecule belonging to the class of organic compounds known as 2-heteroaryl carboxamides. Its structure features an oxazole ring substituted with an amino group at position 2 and a carboxamide group at position 5; the amide nitrogen is further substituted with two phenylmethyl (benzyl) groups. The compound has been cataloged in chemical and drug databases but is not approved for clinical use or any therapeutic indication. It has been studied as a ligand in structural biology contexts but does not have reported pharmacological activity or mechanism of action established in humans[1][4][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 2-amino-N,N-bis(phenylmethyl)-1,3-oxazole-5-carboxamide.